Aurora Cannabis (ACB) Cash & Current Investments (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Cash & Current Investments of $85.2 million for Q1 2026, down 11.31% year-on-year from $96.1 million in Q1 2025, and up 9.62% on a QoQ basis from $77.8 million in Q4 2025.
Aurora Cannabis (ACB) Cash & Current Investments (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Cash & Current Investments for 9 consecutive years, with $85.2 million the latest figure, recorded in Q1 2026.
- Quarterly Cash & Current Investments fell 11.31% year-over-year to $85.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85.2 million (down 11.31% YoY) and the FY2026 annual result came in at $84.6 million, down 14.74% from the prior year.
- Cash & Current Investments rose to $85.2 million in Q1 2026 per ACB's latest filing, from $77.8 million in the prior quarter.
- Over the last five years, Cash & Current Investments for ACB reached as high as $364.0 million in Q2 2022 and fell as low as $77.8 million in Q4 2025.
- A 5-year average of $172.2 million and a median of $146.1 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2023 — Cash & Current Investments tumbled 54.29% — and 2024, when it advanced 0.8%.
- Year by year, Cash & Current Investments stood at $207.4 million in 2022, then decreased by 27.41% to $150.6 million in 2023, then declined by 2.97% to $146.1 million in 2024, then sank by 46.77% to $77.8 million in 2025, then climbed by 9.62% to $85.2 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $85.2 million, $77.8 million, and $103.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Aurora Cannabis | 155.40 Mn | 70.15 Mn | 21.72 Mn | 85.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.25 Mn |
| Dec 31, 2025 | 77.77 Mn |
| Sep 30, 2025 | 103.14 Mn |
| Jun 30, 2025 | 134.26 Mn |
| Mar 31, 2025 | 96.12 Mn |
| Dec 31, 2024 | 146.10 Mn |
| Sep 30, 2024 | 127.73 Mn |
| Jun 30, 2024 | 167.73 Mn |
| Mar 31, 2024 | 101.56 Mn |
| Dec 31, 2023 | 150.58 Mn |
| Sep 30, 2023 | 143.83 Mn |
| Jun 30, 2023 | 166.39 Mn |
| Mar 31, 2023 | 189.06 Mn |
| Dec 31, 2022 | 207.45 Mn |
| Sep 30, 2022 | 302.78 Mn |
| Jun 30, 2022 | 364.00 Mn |
| Mar 31, 2022 | 362.87 Mn |
| Dec 31, 2021 | 292.85 Mn |
| Sep 30, 2021 | 329.89 Mn |
| Jun 30, 2021 | 391.18 Mn |